Spots Global Cancer Trial Database for adult synovial sarcoma
Every month we try and update this database with for adult synovial sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | NCT00052754 | Sarcoma | gefitinib | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma | NCT01281865 | Adult Synovial ... Recurrent Adult... Stage III Adult... Stage IV Adult ... | diagnostic labo... everolimus imatinib mesyla... | 18 Years - | National Cancer Institute (NCI) | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | NCT00002764 | Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide conventional su... | 16 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma | NCT01281865 | Adult Synovial ... Recurrent Adult... Stage III Adult... Stage IV Adult ... | diagnostic labo... everolimus imatinib mesyla... | 18 Years - | National Cancer Institute (NCI) | |
| Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma | NCT00064220 | Sarcoma | soblidotin | 15 Years - | Daiichi Sankyo | |
| STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | NCT00006357 | Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine... | imatinib mesyla... | 15 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor | NCT00069940 | Brain and Centr... Gastrointestina... Sarcoma | sargramostim telomerase: 540... | 2 Years - | Dana-Farber Cancer Institute | |
| Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis | NCT00091351 | Sarcoma | conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma | NCT00053794 | Endometrial Can... Sarcoma | perifosine | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | NCT00104949 | Sarcoma | trastuzumab | 18 Years - | National Cancer Institute (NCI) | |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma | NCT00027911 | Sarcoma | NY-ESO-1 peptid... sargramostim | 18 Years - | Columbia University | |
| Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00003939 | Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine... | trabectedin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00041236 | Sarcoma | exatecan mesyla... | 15 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | NCT00041249 | Gastrointestina... Sarcoma | brostallicin | 15 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00003939 | Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine... | trabectedin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery | NCT00450736 | Childhood Malig... Sarcoma | celecoxib adjuvant therap... radiation thera... | 18 Years - 120 Years | University of Miami | |
| Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | NCT00002641 | Endometrial Can... Kidney Cancer Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide isolated perfus... adjuvant therap... conventional su... radiation thera... | 16 Years - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma | NCT00423618 | Sarcoma | radiotherapy | 16 Years - 120 Years | Sheffield Teaching Hospitals NHS Foundation Trust | |
| Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00041236 | Sarcoma | exatecan mesyla... | 15 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma | NCT00410462 | Ovarian Cancer Sarcoma Small Intestine... | brostallicin doxorubicin hyd... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma | NCT00030784 | Sarcoma | ifosfamide pegylated lipos... | 18 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma | NCT01189253 | Sarcoma | doxorubicin hyd... trabectedin laboratory biom... quality-of-life... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | NCT00061984 | Sarcoma | pegfilgrastim doxorubicin hyd... ifosfamide multimodality t... | 18 Years - 60 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | NCT00052754 | Sarcoma | gefitinib | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | NCT00104949 | Sarcoma | trastuzumab | 18 Years - | National Cancer Institute (NCI) | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | NCT00002764 | Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide conventional su... | 16 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor | NCT00069940 | Brain and Centr... Gastrointestina... Sarcoma | sargramostim telomerase: 540... | 2 Years - | Dana-Farber Cancer Institute | |
| Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma | NCT00003052 | Sarcoma | doxorubicin hyd... etoposide ifosfamide conventional su... hyperthermia tr... radiation thera... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | NCT00041249 | Gastrointestina... Sarcoma | brostallicin | 15 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery | NCT00450736 | Childhood Malig... Sarcoma | celecoxib adjuvant therap... radiation thera... | 18 Years - 120 Years | University of Miami | |
| Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma | NCT00245102 | Adult Angiosarc... Adult Epithelio... Adult Leiomyosa... Adult Malignant... Adult Neurofibr... Adult Synovial ... Ovarian Sarcoma Recurrent Adult... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin... Uterine Carcino... Uterine Leiomyo... | sorafenib tosyl... | 18 Years - | National Cancer Institute (NCI) | |
| Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX | NCT00900211 | Sarcoma | microarray anal... molecular diagn... biologic sample... | 16 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
